Trial Profile
Phase 1/2 combination study of Genolimzumab in Australia
Status:
Not stated
Phase of Trial:
Phase I/II
Latest Information Update: 01 Nov 2017
Price :
$35
*
At a glance
- Drugs Geptanolimab (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2017 New trial record
- 30 Oct 2017 According to a CBT Pharmaceuticals media release, this trial is expected to begin in the second half of 2018.